[DISCLOSURE] Neopharm (092730) reported on Aug. 9 that its consolidated operating profit in second-quarter increased 99.4 percent to 2.9 billion won (US$2 million) on-year.

Sales rose 39.5 percent to 9.4 billion won and net profit went up 114 percent 1.8 billion won.